Greystone Associates

The Power of Insight

Market Knowledge

Biologicals

Cardiology

Disease Therapeutics

Drug Delivery

Immunology

Patient Monitoring

Wound Care

Strategic Planning

Business Development

Technology Management

Autoimmune Disease Therapeutics

As a group, autoimmune diseases represent one of the most intractable families of conditions facing medical science. The complexities and genetic underpinnings of the human immune response result in a set of disease targets that are at once physiologically ubiquitous and highly individualized. Until recently, autoimmune disease patients were .....more

Immune Modulation Therapeutics

Drugs based on immune factors - a class that includes cytokines, lymphocyte receptors, signaling enzymes, antibodies and transcription factors - have demonstrated the capability to effectively treat a host of diseases that had previously been considered to be intractable.........more

Therapeutic Cancer Vaccines

Therapeutic cancer vaccines, long deemed one of the most commercially attractive pharmaceutical business opportunities and a highly-cherished health care objective, are beginning to show promise for a number of cancers. A growing list of companies are entering the race to .........more

Asthma and COPD Therapeutics

As the number of asthmatics, COPD, and allergy patients continues to grow, the upper respiratory treatment market is attracting a number of new companies – companies with some novel approaches to the problem of chronic airway inflammation. These companies are conducting ongoing........more

Autoimmune Markets for Therapeutic Biologicals

A number of potentially important pipeline drugs hold the promise of future improvements in outcomes for autoimmune disease patients. This study analyzes current autoimmune therapeutics and assesses the next-generation of candidates and their probable impact on treatment options and ,,,,more